A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas
EvolveImmune United, Inc
EvolveImmune United, Inc
Seagen Inc.
Pfizer
IDEAYA Biosciences
Neonc Technologies, Inc.
MacroGenics
Innate Pharma
Mayo Clinic
DualityBio Inc.
UNICANCER
Cofactor Genomics, Inc.